Innovative Medicines

Pipeline & Partnering

Fosun Pharma USA is a US-focused innovative specialty pharma company driven by our internal R&D and strategic partnershipS

About Us

It's important to care for others and contribute to society

Building a portfolio of high value branded,
innovative products for patients with unmet medical needs

PIPELINE

Established over 10 in-house R&D units based on different technologies and modalities

Our diverse pipeline reflects therapeutic areas of interest including:

  • Hematology and Oncology
  • Rare Diseases
  • Immunology
  • CNS
  • Cardiovascular System
  • Infectious Disease

Seeking strategic partnerships
across many therapeutic areas and modalities

THERAPEUTIC AREAS
  • Oncology
  • Autoimmune/Inflamation
  • Metabolic Disease
  • Neuroscience
  • Rare Diseases
DRUG MODALITYIES
  • Small Molecules
  • Antibodies, including monoclonal, bispecific and ADC
  • Gene Therapy/CAR T cell therapy
  • Stem cell therapy
  • Others (Oligos, peptides, etc.)

Expanding our pipeline by In-licensing, Co-Development, JV or Acquisition

US RIGHTS
  • Late stage (post POC) clinical projects or commercial products
  • Full development or co-development
  • Full commercialization rights preferred
GLOBAL RIGHTS
  • Open to all stages of preclinical and/or early clinical projects
  • Responsible for full development and commercialization
CHINA RIGHTS
  • Programs that have PoC in clinic and beyond (Phase II/III preferred)
  • Fosun Pharma licenses in or co-develops the program for China
  • Responsible for late-stage development, registration and commercialization in China

Rights for US can be independently negotiated and do not need to be linked to other territories

ENTREPRENEURIAL SPIRIT

Fosun Pharma USA is focused on the identification, development and marketing of innovative assets for the US market

Fosun Pharma USA established a dedicated team with:

  • Extensive large cap pharma experience
  • Local insights and network
  • Alliance management experience
  • Drug development capability
  • Commercial expertise

Ready to work with agility:

  • Honed screening, diligence and transaction approach
  • Nimble team decision making process
Create a global reach, with Fosun Pharma USA
PARTNERSHIP ADVANTAGES

Partnership with Fosun Pharma USA offers:

  • A global reach with a focus on the United States and China markets
  • A full range of established capabilities across geographies including Research, Product Development, Regulatory, Manufacturing, Sales and Marketing
  • A flexible approach to partnering structure including licensing, equity investment, JV, M&A or hybrid of multiple vehicles
  • Contribute to Society: The core embodiment includes the focus on customers and achievement of win-win situations, as well as practicing what one advocates and achievement of the two ecologies.
PARTNERSHIP SUCCESS STORY

In March 2020, BioNTech granted Fosun Pharma exclusive right to develop and commercialize COVID-19 vaccines based on its mRNA technology platform in the Chinese Mainland, Hong Kong SAR, Macau SAR and Taiwan region.

By the end of Feb, 2022, more than 20 million COMIRNATY® (mRNA COVID-19 vaccine) has been administered in Hong Kong, Macau and Taiwan, helping to establish the COVID-19 barrier in the region.

PARTNERSHIP SUCCESS STORY

As a joint venture between Shanghai Fosun Pharmaceutical (Group) Co., Ltd and Kite, a Gilead company in U.S., Fosun Kite is dedicated to the advancement of cell therapy and its commercialization to benefit cancer patients in China.

Fosun Kite has a commercial manufacturing facility of approximately 10,000 m2, and a R&D center of 2,000 m2 with a professionally experienced R&D team. Taking a combined approach of internal R&D effort and external partnering, Fosun Kite has built a sustainable pipeline including CAR-T programs at both discovery and clinical stages.

104 Carnegie Center, Suite 204
Princeton, NJ 08540
(609) 250-2802

info.usa@fosunpharma.com
Customer Service & Adverse Event/ Quality Concerns: (855) 282-4882 or fosuncs@eversana.com

OUR WEBSITE

© 2024 Fosun Pharma USA Inc. All rights reserved.  |  Privacy Notice